EAM
ELV icon

Exome Asset Management’s Elevance Health ELV Stock Holding History

Exome Asset Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.3M Sell
14,677
-2,514
-15% -$826K 2.22% 13
2025
Q4 		$6.03M Buy
+17,191
New +$5.81M 2.88% 10

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Exome Asset Management's ELV Position: Q1 2026 in Review

Exome Asset Management reduced its Elevance Health (ELV) stake by 15% in Q1 2026, selling an estimated $826K and leaving 14,677 shares worth $4.3M. The position accounts for 2.22% of the portfolio, ranked #13.

Exome Asset Management first reported a position in ELV in Q4 2025 and has held it in 2 quarters since. The position peaked at $6.03M in Q4 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Exome Asset Management held 14,677 shares of Elevance Health worth $4.3M as of Q1 2026.
  • Exome Asset Management sold 2,514 Elevance Health shares in Q1 2026, an estimated $826K.
  • Elevance Health made up 2.22% of Exome Asset Management's portfolio in Q1 2026, its #13 holding.
  • Exome Asset Management first reported a position in Elevance Health in Q4 2025 and has held it in 2 quarters since.
  • Exome Asset Management's Elevance Health position peaked at $6.03M in Q4 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Exome Asset Management's 13F filing for Q1 2026, filed 15 May 2026.